0001209191-14-040999.txt : 20140624
0001209191-14-040999.hdr.sgml : 20140624
20140612173027
ACCESSION NUMBER: 0001209191-14-040999
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140610
FILED AS OF DATE: 20140612
DATE AS OF CHANGE: 20140612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070336
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-624-7000
MAIL ADDRESS:
STREET 1: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: QVT Associates GP LLC
CENTRAL INDEX KEY: 0001290166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33095
FILM NUMBER: 14908062
BUSINESS ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-705-8800
MAIL ADDRESS:
STREET 1: 1177 AVENUE OF THE AMERICAS
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-06-10
0
0001070336
ACHILLION PHARMACEUTICALS INC
ACHN
0001290166
QVT Associates GP LLC
1177 AVENUE OF THE AMERICAS, 9TH FLOOR
NEW YORK
NY
10036
0
0
1
0
Common Stock, $0.001 par value
2014-06-10
4
S
0
25200
7.78
D
10791753
I
Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
Common Stock, $0.001 par value
2014-06-10
4
S
0
16425
7.67
D
10775328
I
Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
Common Stock, $0.001 par value
2014-06-11
4
S
0
51024
7.57
D
10724304
I
Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
Common Stock, $0.001 par value
2014-06-11
4
S
0
36000
7.71
D
10688304
I
Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
On June 10, 2014, Quintessence Fund L.P. sold 3,614 shares of Common Stock, QVT Fund IV LP sold 5,489 shares of Common Stock and QVT Fund V LP sold 32,522 shares of Common Stock. On June 11, 2014, Quintessence Fund L.P. sold 7,556 shares of Common Stock, QVT Fund IV LP sold 11,478 shares of Common Stock and QVT Fund V LP sold 67,990 shares of Common Stock. As a result, Quintessence Fund L.P. directly beneficially owns 928,124 shares of Common Stock, QVT Fund IV LP directly beneficially owns 1,409,793 shares of Common Stock and QVT Fund V LP directly beneficially owns 8,350,387 shares of Common Stock. QVT Associates GP LLC is the general partner of QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. (together with QVT Fund IV LP, and QVT Fund V LP, the "Funds"). QVT Financial LP is the investment manager for the Funds and therefore may be deemed the beneficial owner of the Common Stock held by the Funds. QVT Financial GP LLC is the general partner of QVT Financial LP and therefore may be deemed the beneficial owner of Common Stock beneficially owned by QVT Financial LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
/s/ Nick Brumm, Managing Member
2014-06-12